Previous 10 | Next 10 |
Companies focused on developing solutions against monkeypox jumped in the pre-market Monday after New York became the second major U.S. city to call the current outbreak a public health emergency. Announcing the decision on Saturday, New York Mayor Eric Adams and Dr. Ashwin Vasan, c...
Co-Diagnostics, Inc. to Participate in Yale University SalivaDirect™ Conference Held July 28-29 in Chicago PR Newswire SALT LAKE CITY , July 27, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or the "Company"), a molecul...
Co-Diagnostics, Inc. to Announce Expansion of OEM Agreement with Bio Molecular Systems at AACC PR Newswire SALT LAKE CITY , July 26, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or the "Company"), a molecular diagnostics company with ...
The companies offering solutions to monkeypox are on the rise in the pre-market after The World Health Organization classified the current outbreak of the rare viral disease as a public health emergency of international concern (PHEIC) on Saturday. Notable gainers include monkey...
The World Health Organization (WHO) designated the current monkeypox outbreak a public health emergency of international concern (PHEIC) on Saturday. PHEIC designation is WHO's highest level of warning, previously issued for the COVID-19 pandemic and Ebola. The decision follows a ...
Co-Diagnostics, Inc. to Host Booth at AACC Held July 24-28 in Chicago PR Newswire The Company will also be providing an update to its distributors and other customers on July 26 at 11 am CT . SALT LAKE CITY , July 20, 2022 /PRNewswire/...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Specializing in molecular diagnostic polymerase chain reaction (PCR) tests, Co-Diagnostics (NASDAQ: CODX ) represents an extremely relevant business in the new normal. Early this morning, the company announced that it...
The shares of Co-Diagnostics ( NASDAQ: CODX ) reached over a three-month high after the molecular diagnostics company announced the shipment of testing reagents for the monkeypox virus to one of its international distributors. Co-Diagnostics ( CODX ) said that the prod...
Shares of Co-Diagnostics (NASDAQ: CODX) are up by more than 5% as of 9:52 a.m. ET on Monday after the company reported that it sent the first shipment of its new molecular diagnostic test for monkeypox to one of its customers outside the U.S. While management didn't offer any in...
Co-Diagnostics, Inc. Announces Shipment of Monkeypox Virus Test PR Newswire SALT LAKE CITY , July 11, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform ...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago PR Newswire SALT LAKE CITY , July 29, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company wi...
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , July 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States PR Newswire SALT LAKE CITY , July 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company w...